How have MEDS shares performed in 2024?

TRxADE HEALTH's stock was trading at $5.20 on January 1st, 2024. Since then, MEDS shares have increased by 23.7% and is now trading at $6.43. View the best growth stocks for 2024 here .

Are investors shorting TRxADE HEALTH?

TRxADE HEALTH saw a drop in short interest in March. As of March 31st, there was short interest totaling 34,000 shares, a drop of 39.3% from the March 15th total of 56,000 shares. Based on an average trading volume of 417,300 shares, the days-to-cover ratio is currently 0.1 days. Currently, 4.0% of the shares of the stock are sold short. View TRxADE HEALTH's Short Interest .

When is TRxADE HEALTH's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our MEDS earnings forecast .

How were TRxADE HEALTH's earnings last quarter?

TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its quarterly earnings data on Sunday, October, 24th. The company reported ($2.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.95) by $0.45. The business earned $2.55 million during the quarter, compared to the consensus estimate of $1.94 million. TRxADE HEALTH had a negative net margin of 78.18% and a negative trailing twelve-month return on equity of 69.22%. During the same quarter in the prior year, the firm posted $0.30 earnings per share.

How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH?

TRxADE HEALTH announced a dividend on Wednesday, February 28th. Stockholders of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date is Monday, March 25th. Read our dividend analysis for MEDS .

When did TRxADE HEALTH's stock split?

TRxADE HEALTH's stock reverse split on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of TRxADE HEALTH own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD) , Biocept (BIOC) , iBio (IBIO) , Ollie's Bargain Outlet (OLLI) , OPKO Health (OPK) , Alto Ingredients (PEIX) , Tiziana Life Sciences (TLSA) and Trevena (TRVN) .

How do I buy shares of TRxADE HEALTH?

Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:MEDS

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

→ Biden replacement revealed? (From Paradigm Press) (Ad)

Free MEDS Stock Alerts

$6.43

-0.50 (-7.22%)

(As of 04/19/2024 ET)

Compare

Today's Range: $6.35
▼
$7.25
50-Day Range: $4.11
▼
$33.90
52-Week Range: $3.69
▼
$44.56

Volume: 73,499 shs
Average Volume: 361,971 shs
Market Capitalization: $7.78 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get TRxADE HEALTH alerts:

Ad DTI

Here’s how to start a “Weekend Side Hustle” from your sofa

Here’s how you can start your very own “Weekend Side Hustle” right from the comfort of your sofa! It doesn't matter if you have a multi-million dollar retirement account… Or if you’re just starting out with a few thousand.

Weekend after weekend!

About TRxADE HEALTH Stock (NASDAQ:MEDS)

TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.

MEDS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

MEDS Stock News Headlines

April 18, 2024 | msn.com

Lexington among cities with highest cost of prescription medications, study shows

April 17, 2024 | msn.com

What Medications Can Cause Antiphospholipid Syndrome? A Review By Doctors

April 20, 2024 | Paradigm Press (Ad)

Biden replacement revealed?

A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13.

April 17, 2024 | msn.com

On Your Side: Know this about flea and tick medications

April 16, 2024 | americanbankingnews.com

TRxADE HEALTH (NASDAQ:MEDS) Shares Down 0.1%

April 11, 2024 | msn.com

This multifunctional system can send drugs where they can be effective in body’s tissues, organs

April 11, 2024 | msn.com

Hundreds of drugs are in short supply around the U.S., pharmacists warn

April 1, 2024 | msn.com

ZenCortex Review: 180 Days Evaluation – Does This Ear Health Supplement Really Work?

April 20, 2024 | TradingTips (Ad)

3 Sub-$10 Stocks to Buy for 2024

Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances.

March 31, 2024 | msn.com

These Common Medications Could Have Terrifying Side Effects

March 29, 2024 | msn.com

Medicare increase in spending on diabetes drugs could cost seniors more money

March 29, 2024 | msn.com

March 12, 2024 | msn.com

FAIR Meds Act could impact costs for prescriptions

March 12, 2024 | msn.com

A massive cyberattack has some Arizona health providers reeling. Here's what we know

March 11, 2024 | msn.com

Texas health centers awarded over $19 million in grants

March 11, 2024 | msn.com

Lexicon Pharmaceuticals, Mesoblast, Ventyx Biosciences among healthcare movers

March 6, 2024 | msn.com

Crude Oil Rises Sharply; Foot Locker Shares Plunge

March 6, 2024 | msn.com

TRxADE Health Stock Skyrockets: Here's Why

March 6, 2024 | globenewswire.com

TRxADE Health, Inc. Announces Special Cash Dividend

February 20, 2024 | msn.com

New model identifies drugs that shouldn’t be taken together

February 20, 2024 | seekingalpha.com

GCT, VHC and IPWR among mid-day movers

February 20, 2024 | msn.com

TRxADE HEALTH Rises Over 140% - What's Going On?

February 20, 2024 | msn.com

Why Is Trxade Health (MEDS) Stock Up 230% Today?

February 20, 2024 | investorplace.com

Why Is Trxade Health (MEDS) Stock Up 230% Today?

February 19, 2024 | msn.com

There are spurious drugs for cancer, hypertension, cholesterol, pediatric diseases…only lab tests can spot them’

February 6, 2024 | msn.com

Is this a scam? Prescription drugs cost 3 times more in the U.S. than in other wealthy countries

February 2, 2024 | msn.com

Fractyl Health valued at $654.6 mln in tepid debut

See More Headlines

Receive MEDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TRxADE HEALTH and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/24/2021
Dividend Payable: 3/22/2024
Ex-Dividend for 3/22 Dividend: 3/25/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/20/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Drugs, proprietaries, & sundries
Sub-Industry: N/A
Current Symbol: NASDAQ:MEDS
CUSIP: N/A
CIK: 1382574
Web: www.trxade.com
Phone: (800) 261-0281
Fax: 800-265-6932
Employees: 33
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($6.9388)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-3,470,000.00
Net Margins: -78.18%
Pretax Margin: -43.63%
Return on Equity: -69.22%
Return on Assets: -23.52%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.61
Quick Ratio: 0.28

Sales & Book Value

Annual Sales: $11.45 million
Price / Sales: 0.68
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.55 per share
Price / Book: 11.69

Miscellaneous

Outstanding Shares: 1,210,000
Free Float: 622,000
Market Cap: $7.78 million
Optionable: Not Optionable
Beta: 2.01

20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

Mr. Surendra K. Ajjarapu (Age 53)
Founder, Chairman, CEO & Secretary
Comp: $354.23k
Mr. Prashant Patel R.Ph. (Age 50)
Founder, President, COO, Interim CFO, Interim Principal Financial & Accounting Officer and Director
Comp: $147.04k
Dr. Ramesh Kenchappa
Chief Scientific Officer
Mr. David M. Saslow Esq.
Inhouse Counsel
Mr. Jariel Morales
Executive Vice President
Dr. Shafaat Pirani Pharm.D.
Executive Vice President of Alliance Pharma Solutions, LLC

Key Competitors

View All Competitors

MEDS Stock Analysis - Frequently Asked Questions

How have MEDS shares performed in 2024?: TRxADE HEALTH's stock was trading at $5.20 on January 1st, 2024. Since then, MEDS shares have increased by 23.7% and is now trading at $6.43.
View the best growth stocks for 2024 here.
Are investors shorting TRxADE HEALTH?: TRxADE HEALTH saw a drop in short interest in March. As of March 31st, there was short interest totaling 34,000 shares, a drop of 39.3% from the March 15th total of 56,000 shares. Based on an average trading volume of 417,300 shares, the days-to-cover ratio is currently 0.1 days. Currently, 4.0% of the shares of the stock are sold short.
View TRxADE HEALTH's Short Interest.
When is TRxADE HEALTH's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024.
View our MEDS earnings forecast.
How were TRxADE HEALTH's earnings last quarter?: TRxADE HEALTH, Inc. (NASDAQ:MEDS) released its quarterly earnings data on Sunday, October, 24th. The company reported ($2.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.95) by $0.45. The business earned $2.55 million during the quarter, compared to the consensus estimate of $1.94 million. TRxADE HEALTH had a negative net margin of 78.18% and a negative trailing twelve-month return on equity of 69.22%. During the same quarter in the prior year, the firm posted $0.30 earnings per share.

How often does TRxADE HEALTH pay dividends? What is the dividend yield for TRxADE HEALTH?: TRxADE HEALTH announced a dividend on Wednesday, February 28th. Stockholders of record on Monday, March 18th will be paid a dividend of $8.00 per share on Friday, March 22nd. The ex-dividend date is Monday, March 25th.
Read our dividend analysis for MEDS.
When did TRxADE HEALTH's stock split?: TRxADE HEALTH's stock reverse split on Thursday, June 22nd 2023. The 1-15 reverse split was announced on Thursday, June 22nd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 22nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.
What other stocks do shareholders of TRxADE HEALTH own?: Based on aggregate information from My MarketBeat watchlists, some companies that other TRxADE HEALTH investors own include Advanced Micro Devices (AMD), Biocept (BIOC), iBio (IBIO), Ollie's Bargain Outlet (OLLI), OPKO Health (OPK), Alto Ingredients (PEIX), Tiziana Life Sciences (TLSA) and Trevena (TRVN).
How do I buy shares of TRxADE HEALTH?: Shares of MEDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MEDS) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

TRxADE HEALTH (MEDS) Stock Price, News & Analysis

About TRxADE HEALTH Stock (NASDAQ:MEDS)

MEDS Stock Price History

MEDS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

MEDS Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info